TY - JOUR AU - Puing, Alfredo AU - Epstein, David AU - Banaei, Niaz AU - Subramanian, Aruna AU - Liu, Anne T1 - Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis T2 - Emerging Infectious Disease journal PY - 2021 VL - 27 IS - 10 SP - 2734 SN - 1080-6059 AB - Prophylactic trimethoprim/sulfamethoxazole (TMP/SMX) prevents Pneumocystis jirovecii pneumonia and nocardiosis in immunocompromised patients but sometimes is avoided because of purported allergies or side effects. Of 25 immunocompromised patients receiving alternative prophylaxis in whom nocardiosis developed, 16 subsequently tolerated TMP/SMX treatment. Clinicians should consider TMP/SMX allergy evaluation and rechallenging to assess patient tolerance. KW - Nocardia KW - immunocompromised KW - trimethoprim/sulfamethoxazole KW - sulfa KW - drug allergy KW - bacteria KW - fungi KW - Pneumocystis jirovecii KW - respiratory infections DO - 10.3201/eid2710.210620 UR - https://wwwnc.cdc.gov/eid/article/27/10/21-0620_article ER - End of Reference